# Cachexia in NSCLC Patients: Diagnosis, Characterization, Prognosis, Functional and Skeletal Muscle Implications

> **NCT03960034** · — · COMPLETED · sponsor: **Instituto do Cancer do Estado de São Paulo** · enrollment: 60 (actual)

## Conditions studied

- NSCLC Stage IV

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03960034
- **Lead sponsor:** Instituto do Cancer do Estado de São Paulo
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-10
- **Primary completion:** 2020-12-30
- **Final completion:** 2020-12-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03960034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03960034, "Cachexia in NSCLC Patients: Diagnosis, Characterization, Prognosis, Functional and Skeletal Muscle Implications". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT03960034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*